keratoendotheliitis fugax hereditaria autosomal dominantly inherited disease cornea caused point mutation also known humans encoded gene located long arm chromosome keratoendotheliitis fugax hereditaria patients suffer periodical transient inflammation corneal endothelium stroma leading short term obscuration vision patients repeated attacks central corneal stromal approximately known cases reported literature disease far described finland exome databases suggest may widely distributed people european keratoendotheliitis fugax hereditaria thought belong cryopyrinassociated periodic syndromes patients experience repeated unilateral attacks keratitis times per year beginning age years men women equally affected attacks get less severe less frequent middle age seasonal variation reported symptoms redness eye pain photophobia attack may associated anterior chamber flare symptoms disappear days blurred vision may last weekscitation needed acute symptoms slit lamp shows pseudoguttae dark patches corneal endothelium thought represent patchy corneal endothelial swelling endothelium appears normal attacks attack misdiagnosed treated acute iridocyclitis visual acuity transiently deteriorates attackcitation needed older patients may show faint definite central horizontally oval bilateral stromal opacities opacities may associated decreased visual acuity severe enough need corneal transplantationcitation needed keratoendotheliitis fugax hereditaria inherited autosomal dominant manner meaning affected individual must inherit one mutated allele one parent protein cryopyrin coded gene located disease frequent population common mutation accounting reported cases population described populations however mutation found exome databases minor allele frequency maf finnish maf aggregated nonfinnish european upon clinical suspicion diagnostic testing consist identifying cornea pseudoguttata using specular microscope confocal microscope molecular genetic testing also patients reported benefit immediate treatment attacks topical corticosteroid nonsteroidal antiinflammatory drug nsaid applied times day one week patients found benefit oral nsaidcitation needed repeated corneal inflammation time lead reduced visual acuitycitation needed keratoendotheliitis fugax hereditaria first described olavi valle finnish ophthalmologist interest hereditary eye diseases reported disease keratitis fugax hereditaria family affected members two decades later second finnish family affected members generations reported finnish ophthalmologists highlighted transient corneal endothelial changes proposed term keratoendotheliitis fugax httpsenwikipediaorgwikikeratoendotheliitisfugaxhereditaria